Skip to main content
Clinical Trials/NCT02041143
NCT02041143CompletedPhase 1

Effects of Protein Intake on Muscle Protein Synthesis and Whole Body Protein Balance During an Overnight Fast: an Exploratory Study

Société des Produits Nestlé (SPN)2 sites in 1 country17 target enrollmentStarted: February 1, 2014Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
17
Locations
2
Primary Endpoint
muscle FSR determination

Study Overview

Brief Summary

This trial is an exploratory study in order to determine whether the ingestion of one type of protein (milk protein/CHO/Fat) vs.placebo (CHO/Fat) 2 hours before bed time results in the extension of the post-prandial window of anabolism during the night by increasing whole body protein balance as well as muscle protein fractional synthesis rate (FSR).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
55 Years to 65 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy as determined by the medical questionnaire and the medical visit including blood sampling
  • 55-65y of age
  • BMI (19.0 - 25.0 kg/ m²)
  • Having signed the consent form

Exclusion Criteria

  • Digestive (intestinal, gastric, hepatic or pancreatic), renal or metabolic disease, as determined by the medical (screening) visit and a blood chemistry analysis (glucose, total cholesterol, LDL, HDL, triglycerides, aspartate transaminase, alanine aminotransferase, gamma glutamyl transpeptidase, C Reactive Protein, creatinin)
  • Heart or other organ disease
  • Arterial hypertension (Systolic pressure ≥ 140 mmHg or diastolic pressure ≥ 90 mmHg)
  • Any clotting trouble (diagnosed by Prothrombin time (PT), activated Partial Thromboplastin Time (aPTT), fibrinogen measures and platelets number (the latter is part of a classical blood cells counting at screening)
  • Any inflammatory disease in the past four weeks
  • Use of specific medications
  • Recent major surgery (3 months)
  • History of major gastro-intestinal surgery (gastric bypass, intestinal resection etc...)
  • History of cancer within the past year
  • Significant weight loss during the last 3 months (5% and more)
  • Food allergies, especially cow milk protein allergies
  • Special diets especially vegetarian, high protein or weight loss program (anamnesis)
  • High level structured exercise 3 times a week (e.g.: fitness club, competitions...)
  • Have a high alcohol consumption (more than 2 drinks/day)
  • Consumption of illicit drugs anamnesis only
  • Having given blood within the last month, or willing to make a blood donation until one month following the end of the study
  • Subject who cannot be expected to comply with the study procedures, including consuming the test products.
  • Currently participating or having participated in another clinical trial during the last month prior to the beginning of this study

Outcomes

Primary Outcomes

muscle FSR determination

Time Frame: Within 24 hours of product intake

Muscle protein FSR (fractional synthesis rate) will be determined using primed constant infusions of \[13C6\] phenylalanine for 5 hours starting around from 03:00 a.m. (see flow chart attached). Whole body protein balance will be measured throughout the night using \[15N\]glycine (200mg) which will be orally taken with the trial product in the evening.

Secondary Outcomes

  • Activation of signaling pathways involved in skeletal muscle protein balance(Within 24 hours after product intake)
  • Glucose metabolism(Within 24 hours after product intake)
  • Plasma amino acid availability(Within 24 hours after product intake)

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials